Yin Y, Xie Y, Ge W, Li Y
This is especially true for patients with class II or class III obesity, patients with obesity-related medical problems, and patients who have lost and regained weight many times
However, tirzepatide (Mounjaro), Wegovy (semaglutide), and liraglutide (Nevolat) have all been shown to effectively support weight loss
There were no major side effects that led to withdrawal from the clinical trial prior to the last assessment
Gastric Electrical Stimulation For a subset of patients with severe, refractory gastroparesis that is unresponsive to medical therapy, gastric electric stimulation (GES) may be an option
Grossauer A, Hemicker G, Krismer F, Peball M, Djamshidian A, Poewe W, et al